Alcon Inc. (BVMF:A2LC34)

Market Cap	192.12B -28.5%
Revenue (ttm)	57.29B +4.9%
Net Income	5.40B -3.7%
EPS	10.91 -3.4%
Shares Out	n/a
PE Ratio	35.59
Forward PE	21.42
Dividend	0.12 (0.29%)
Ex-Dividend Date	May 13, 2025

Volume	1
Average Volume	5
Open	39.37
Previous Close	39.80
Day's Range	39.37 - 39.37
52-Week Range	39.20 - 55.60
Beta	n/a
RSI	36.08
Earnings Date	Feb 25, 2026

About Alcon

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company’s cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS...

• Industry: Ophthalmic Goods
• Founded: 1945
• Employees: 25,942
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: A2LC34

Financial Performance

In 2025, Alcon's revenue was $10.40 billion, an increase of 4.94% compared to the previous year's $9.91 billion. Earnings were $980.00 million, a decrease of -3.73%.

Financial numbers in USD